Tumors typically showed whole chr.9 loss, likely targeting multiple tumor suppressors (i.e. INK4A, PTCH1, and TSC1) whereas the cell lines had a high frequency of both gains and losses of chromosome 9, often in association with UPD affecting either the whole chromosome or its q-arm (Figure 4). Here, CDKN2A is linked to neoplasm.